Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Cardiff Oncology, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 90 | 1 | 83 | −6 |
| Shares | 13.1M | 2.63M | 12.8M | +2.30M (+22.0%) |
| Value | $29.1M | $5.84M | $34.1M | +$10.9M (+46.8%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Cardiff Oncology, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 2,735,581 | $7.30M | 0.00% |
| AQR Capital Management LLC | 30,869 | $82.4K | 0.00% |
| SG Americas Securities, LLC | 23,937 | $64.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 21,834 | $58.3K | 0.00% |
| Baker Ellis Asset Management LLC | 20,000 | $53.4K | 0.01% |
| Commonwealth Equity Services, LLC | 17,655 | $47.0K | 0.00% |
| Sterling Capital Management LLC | 92 | $246 | 0.00% |
| Nisa Investment Advisors, LLC | 22 | $59 | 0.00% |
| CWM, LLC | 41 | $0 | 0.00% |
Sold out (15)
Institutions that held Cardiff Oncology, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| UBS Oconnor LLC | 150,000 | $333.0K |
| Jump Financial, LLC | 85,838 | $190.6K |
| Cubist Systematic Strategies, LLC | 68,730 | $152.6K |
| Man Group plc | 53,357 | $118.5K |
| Graham Capital Management, L.P. | 41,922 | $93.1K |
| Alpine Global Management, LLC | 37,924 | $84.2K |
| Susquehanna International Group, LLP | 35,970 | $79.9K |
| Paloma Partners Management Co | 29,090 | $64.6K |
| Squarepoint Ops LLC | 18,045 | $40.1K |
| Marathon Trading Investment Management LLC | 17,580 | $39.0K |
| Ground Swell Capital, LLC | 17,098 | $38.0K |
| Occudo Quantitative Strategies LP | 14,566 | $32.3K |
| Point72 (DIFC) Ltd | 12,284 | $27.3K |
| America First Investment Advisors, LLC | 4,000 | $8.88K |
| Front Row Advisors LLC | 2 | $4 |
Not filed for Q3 2024 yet (1)
Institutions that held Cardiff Oncology, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 2,628,407 | $5.84M |